Literature DB >> 223616

Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.

M J Rance.   

Abstract

1 The pharmacology of analgesic drugs with mixed agonist-antagonist action is reviewed in the light of the theory of drug action at single and multiple receptors. 2 Evidence for a heterogeneous population of opiate receptors in mammalian brain and in isolated tissue preparations is discussed. 3 The unusual pharmacological and pharmacokinetic profiles of the oripavine derivative buprenorphine are discussed in relation to the action of the drug at a molecular level.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223616      PMCID: PMC1429313          DOI: 10.1111/j.1365-2125.1979.tb04701.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics.

Authors:  L C HENDERSHOT; J FORSAITH
Journal:  J Pharmacol Exp Ther       Date:  1959-03       Impact factor: 4.030

2.  Analgesimetry and ranking of analgesic drugs by the receptacle method.

Authors:  J BEN-BASSAT; E PERETZ; F G SULMAN
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-11-01

3.  The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man.

Authors:  L LASAGNA; H K BEECHER
Journal:  J Pharmacol Exp Ther       Date:  1954-11       Impact factor: 4.030

4.  A comparison of heat and pressure analgesiometric methods in rats.

Authors:  A F GREEN; P A YOUNG
Journal:  Br J Pharmacol Chemother       Date:  1951-12

5.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

6.  History and development of mixed opioid agonists, partial agonists and antagonists.

Authors:  W R Martin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular route.

Authors:  J M Orwin; J Orwin; M Price
Journal:  Acta Anaesthesiol Belg       Date:  1976

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.

Authors:  A Cowan; J W Lewis; I R Macfarlane
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

10.  The animal pharmacology of buprenorphine, an oripavine analgesic agent.

Authors:  A Cowan; J C Doxey; E J Harry
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

View more
  11 in total

Review 1.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

2.  Side-effects of mixed agonist-antagonist analgesics used in sequential anaesthesia.

Authors:  C Devaux; P Schoepffler; J P Gauthier-Lafaye
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Mixed agonist-antagonist opiates and physical dependence.

Authors:  J J Jacob; G M Michaud; E C Tremblay
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice.

Authors:  U Filibeck; C Castellano; A Oliverio
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment.

Authors:  Sarah L Withey; Roger D Spealman; Jack Bergman; Carol A Paronis
Journal:  J Pharmacol Exp Ther       Date:  2019-08-14       Impact factor: 4.030

Review 6.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

7.  Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat.

Authors:  A G Hayes; M Skingle; M B Tyers
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

8.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

Review 9.  Propiram. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use as an analgesic.

Authors:  Karen L Goa; Rex N Brogden
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.